Nabumetone

CHEMBL1070 Phase 4 معتمد Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
228.3 g/mol
LogP
3.1
Phase
4

This non-steroidal anti-inflammatory drug (NSAID) is used to relieve pain, swelling, and stiffness caused by arthritis. It works by blocking enzymes that produce inflammatory chemicals in the body, and it is taken once or twice daily with food to reduce stomach upset.

الوزن الجزيئي

228,2900 g/mol

LogP

3,10

TPSA

26,30 Ų

قاعدة ليبينسكي للخمسة

ناجح

المجالات العلاجية

آلية العمل

Inhibits cyclooxygenase (COX-1 and/or COX-2) enzymes, reducing the synthesis of prostaglandins and thromboxanes from arachidonic acid. This produces anti-inflammatory, analgesic, and antipyretic effects.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

الآلية

Inhibits cyclooxygenase (COX-1 and/or COX-2) enzymes, reducing the synthesis of prostaglandins and thromboxanes from arachidonic acid. This produces anti-inflammatory, analgesic, and antipyretic effects.

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COc1ccc2cc(CCC(C)=O)ccc2c1

InChI

InChI=1S/C15H16O2/c1-11(16)3-4-12-5-6-14-10-15(17-2)8-7-13(14)9-12/h5-10H,3-4H2,1-2H3

Molecular Formula

C15H16O2

HBD / HBA

- / 2

الروابط القابلة للدوران

4

الذرات الثقيلة

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

This non-steroidal anti-inflammatory drug (NSAID) is used to relieve pain, swelling, and stiffness caused by arthritis. It works by blocking enzymes that produce inflammatory chemicals in the body, and it is taken once or twice daily with food to reduce stomach upset.

Inhibits cyclooxygenase (COX-1 and/or COX-2) enzymes, reducing the synthesis of prostaglandins and thromboxanes from arachidonic acid. This produces anti-inflammatory, analgesic, and antipyretic effects.

Yes, Nabumetone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1070. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4409. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.